PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27446311-7	2016	In conclusion, RBP4 may be an effective predictor for diabetic atherosclerosis; pioglitazone is able to decrease RBP4 and NF-kappaB, which may partly contribute to its protective effect against diabetic atherosclerosis.	Pioglitazone	80-92	retinol binding protein 4	Rattus norvegicus	113-117	
25634757-0	2015	Pioglitazone lowers serum retinol binding protein 4 by suppressing its expression in adipose tissue of obese rats.	Pioglitazone	0-12	retinol binding protein 4	Rattus norvegicus	26-51	
25634757-3	2015	We investigated whether, and how, pioglitazone modulates serum level of retinol binding protein 4 (RBP4), an adipocytokine associated with obesity and insulin resistance.	Pioglitazone	34-46	retinol binding protein 4	Rattus norvegicus	72-97	
25634757-3	2015	We investigated whether, and how, pioglitazone modulates serum level of retinol binding protein 4 (RBP4), an adipocytokine associated with obesity and insulin resistance.	Pioglitazone	34-46	retinol binding protein 4	Rattus norvegicus	99-103	
25634757-5	2015	RESULTS: Pioglitazone treatment significantly decreased serum RBP4 levels in obese rats, which was correlated with reduced body weight and increased insulin sensitivity.	Pioglitazone	9-21	retinol binding protein 4	Rattus norvegicus	62-66	
25634757-6	2015	Moreover, pioglitazone greatly decreased RBP4 mRNA and protein levels in adipose tissue but not in the liver.	Pioglitazone	10-22	retinol binding protein 4	Rattus norvegicus	41-45	
25634757-8	2015	CONCLUSION: These results demonstrate that pioglitazone inhibits the level of serum RPB4 by suppressing RBP4 expression in adipose tissue of obese rats, suggesting that inhibiting RBP4 expression in adipocytes may provide a mechanism by which pioglitazone improves insulin sensitivity in insulin-resistant subjects.	Pioglitazone	43-55	retinol binding protein 4	Rattus norvegicus	104-108	
25634757-8	2015	CONCLUSION: These results demonstrate that pioglitazone inhibits the level of serum RPB4 by suppressing RBP4 expression in adipose tissue of obese rats, suggesting that inhibiting RBP4 expression in adipocytes may provide a mechanism by which pioglitazone improves insulin sensitivity in insulin-resistant subjects.	Pioglitazone	43-55	retinol binding protein 4	Rattus norvegicus	180-184